Clinical Trial Update: Apelin Levels and G212A Polymorphism of Apelin Receptor (APJ)

View source ↗

Summary

A completed clinical trial update examines circulating apelin levels and the G212A APJ receptor polymorphism in obesity and insulin resistance, including type 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Obesity
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Aristotle University Of Thessaloniki | Conditions: Obesity, Insulin Resistance | Status: COMPLETED | Results posted: 2016-05-19